Menu
Back to User profile » Mr Richard Pollock
Papers published by Mr Richard Pollock:
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
Hu S, Wu D, Wu J, Zhang Y, Bøgelund M, Pöhlmann J, Pollock RF
Patient Related Outcome Measures 2023, 14:253-267
Published Date: 26 September 2023
A Cost-Utility Analysis of SQ® Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
Pollock RF, Slættanes AK, Brandi H, Grand TS
ClinicoEconomics and Outcomes Research 2023, 15:69-86
Published Date: 3 February 2023
Economic Analysis of Intravenous Iron in Patients with Iron Deficiency Anemia Due to Inflammatory Bowel Disease: Considerations for Clinicians [Letter]
Pollock RF, Dhar A, Johnson M
ClinicoEconomics and Outcomes Research 2022, 14:163-165
Published Date: 4 April 2022
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization
Pollock RF, Colaone F, Shergill S, Brennan VK, Agirrezabal I
ClinicoEconomics and Outcomes Research 2021, 13:835-841
Published Date: 22 September 2021
An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland
Pollock RF, Muduma G
ClinicoEconomics and Outcomes Research 2021, 13:9-18
Published Date: 7 January 2021
Impact of Stigma on People Living with Chronic Hepatitis B
Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, Bonroy K
Patient Related Outcome Measures 2020, 11:95-107
Published Date: 9 March 2020
Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
Vogelberg C, Hamelmann E, Wahn U, Domdey A, Pollock RF, Grand TS
ClinicoEconomics and Outcomes Research 2019, 11:637-649
Published Date: 6 November 2019
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Pollock RF, Chubb B, Valentine WJ, Heller S
Diabetes, Metabolic Syndrome and Obesity 2018, 11:217-226
Published Date: 16 May 2018
An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland
Pollock RF, Meckley LM
ClinicoEconomics and Outcomes Research 2018, 10:223-229
Published Date: 10 April 2018
A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000
Pollock RF, Muduma G
ClinicoEconomics and Outcomes Research 2017, 9:475-483
Published Date: 10 August 2017
Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF
Patient Preference and Adherence 2014, 8:391-399
Published Date: 28 March 2014
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
Pollock RF, Qian Y, Wisniewski T, Seitz L, Kappelgaard AM
Medical Devices: Evidence and Research 2013, 6:107-114
Published Date: 1 August 2013